Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chlamydia Infections | 28 | 2013 | 364 | 3.490 |
Why?
|
Chlamydia trachomatis | 22 | 2013 | 245 | 3.120 |
Why?
|
Sexually Transmitted Diseases | 15 | 2011 | 622 | 1.930 |
Why?
|
Gonorrhea | 17 | 2012 | 335 | 1.410 |
Why?
|
Syphilis | 9 | 2012 | 226 | 1.120 |
Why?
|
Mass Screening | 27 | 2013 | 5238 | 1.120 |
Why?
|
Syphilis, Congenital | 8 | 2006 | 24 | 1.100 |
Why?
|
Pelvic Inflammatory Disease | 5 | 2012 | 94 | 0.780 |
Why?
|
Neisseria gonorrhoeae | 6 | 2012 | 238 | 0.770 |
Why?
|
Sexual Partners | 8 | 2012 | 730 | 0.700 |
Why?
|
Contact Tracing | 4 | 2012 | 272 | 0.660 |
Why?
|
Herpesvirus 2, Human | 3 | 2009 | 185 | 0.650 |
Why?
|
Herpes Genitalis | 2 | 2009 | 141 | 0.590 |
Why?
|
Family Planning Services | 5 | 2012 | 258 | 0.500 |
Why?
|
Pregnancy, Ectopic | 2 | 2012 | 141 | 0.460 |
Why?
|
Pregnancy Complications, Infectious | 12 | 2011 | 2026 | 0.440 |
Why?
|
Urethritis | 1 | 2012 | 22 | 0.420 |
Why?
|
Population Surveillance | 11 | 2009 | 2616 | 0.410 |
Why?
|
Sexual Behavior | 10 | 2012 | 2050 | 0.380 |
Why?
|
Prenatal Care | 11 | 2011 | 1088 | 0.370 |
Why?
|
Herpes Simplex | 3 | 2008 | 466 | 0.360 |
Why?
|
Preventive Health Services | 3 | 2006 | 575 | 0.350 |
Why?
|
Ciprofloxacin | 3 | 2012 | 314 | 0.330 |
Why?
|
Prisoners | 2 | 2009 | 296 | 0.330 |
Why?
|
Managed Care Programs | 2 | 2012 | 949 | 0.330 |
Why?
|
Infant Mortality | 6 | 2011 | 754 | 0.320 |
Why?
|
Disease Outbreaks | 4 | 2006 | 1768 | 0.300 |
Why?
|
Disease Notification | 1 | 2008 | 97 | 0.300 |
Why?
|
Antiprotozoal Agents | 1 | 2007 | 86 | 0.290 |
Why?
|
Health Plan Implementation | 1 | 2009 | 351 | 0.280 |
Why?
|
Syphilis, Latent | 1 | 2005 | 2 | 0.270 |
Why?
|
Practice Guidelines as Topic | 7 | 2011 | 7276 | 0.260 |
Why?
|
Insecticides | 1 | 2007 | 195 | 0.260 |
Why?
|
Syphilis Serodiagnosis | 1 | 2005 | 35 | 0.260 |
Why?
|
United States | 47 | 2012 | 69693 | 0.260 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2008 | 1320 | 0.260 |
Why?
|
Refugees | 1 | 2012 | 510 | 0.250 |
Why?
|
Herpesvirus 1, Human | 2 | 2007 | 742 | 0.240 |
Why?
|
Program Evaluation | 2 | 2011 | 2485 | 0.230 |
Why?
|
Anti-Infective Agents | 3 | 2012 | 971 | 0.230 |
Why?
|
Neonatal Screening | 1 | 2008 | 591 | 0.220 |
Why?
|
Adolescent | 50 | 2013 | 85649 | 0.220 |
Why?
|
Antigens, Viral | 1 | 2007 | 1034 | 0.210 |
Why?
|
Treponema pallidum | 3 | 2008 | 40 | 0.210 |
Why?
|
Female | 100 | 2013 | 379592 | 0.210 |
Why?
|
Thimerosal | 1 | 2001 | 16 | 0.200 |
Why?
|
Radiosurgery | 2 | 2008 | 1309 | 0.200 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2001 | 31 | 0.200 |
Why?
|
Respiration | 1 | 2008 | 1645 | 0.200 |
Why?
|
Robotics | 2 | 2008 | 892 | 0.200 |
Why?
|
Pregnancy | 32 | 2012 | 29087 | 0.200 |
Why?
|
Anti-Bacterial Agents | 7 | 2011 | 7153 | 0.200 |
Why?
|
Maternal Health Services | 1 | 2006 | 452 | 0.190 |
Why?
|
Community Health Services | 1 | 2006 | 650 | 0.190 |
Why?
|
Fetal Death | 4 | 2011 | 447 | 0.190 |
Why?
|
Movement | 1 | 2008 | 1470 | 0.190 |
Why?
|
Humans | 129 | 2022 | 742088 | 0.190 |
Why?
|
Prevalence | 23 | 2012 | 15194 | 0.190 |
Why?
|
Age Distribution | 5 | 2013 | 2900 | 0.180 |
Why?
|
Hepatitis B Vaccines | 1 | 2001 | 194 | 0.180 |
Why?
|
Sexual Abstinence | 1 | 1999 | 16 | 0.170 |
Why?
|
Otitis Media | 2 | 2000 | 277 | 0.170 |
Why?
|
Young Adult | 17 | 2012 | 56350 | 0.170 |
Why?
|
Lung Neoplasms | 8 | 2022 | 13019 | 0.160 |
Why?
|
Models, Statistical | 2 | 2013 | 5100 | 0.160 |
Why?
|
Male | 65 | 2012 | 349538 | 0.160 |
Why?
|
Cephalosporins | 3 | 2008 | 203 | 0.150 |
Why?
|
Penicillin G Benzathine | 3 | 2011 | 24 | 0.150 |
Why?
|
Parenteral Nutrition, Total | 1 | 1998 | 300 | 0.150 |
Why?
|
Infant, Newborn, Diseases | 3 | 2001 | 580 | 0.150 |
Why?
|
Infant, Newborn | 20 | 2011 | 25575 | 0.150 |
Why?
|
Clinical Laboratory Techniques | 1 | 2002 | 740 | 0.150 |
Why?
|
Adult | 59 | 2013 | 213712 | 0.150 |
Why?
|
Vaginal Smears | 1 | 2000 | 511 | 0.140 |
Why?
|
Condoms | 4 | 2009 | 323 | 0.140 |
Why?
|
Pregnancy Complications | 5 | 2010 | 2861 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2022 | 5171 | 0.140 |
Why?
|
Gestational Age | 7 | 2011 | 3490 | 0.140 |
Why?
|
Genital Diseases, Female | 2 | 2010 | 197 | 0.130 |
Why?
|
Alcoholism | 4 | 1999 | 1904 | 0.130 |
Why?
|
Vaginosis, Bacterial | 2 | 2011 | 127 | 0.130 |
Why?
|
Infertility | 2 | 2012 | 655 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1996 | 214 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1996 | 654 | 0.120 |
Why?
|
Public Health | 5 | 2013 | 2594 | 0.120 |
Why?
|
Ambulatory Care Facilities | 3 | 2011 | 932 | 0.120 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2014 | 94 | 0.120 |
Why?
|
Idaho | 2 | 2012 | 16 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 1998 | 514 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3151 | 0.110 |
Why?
|
Azithromycin | 2 | 2006 | 195 | 0.110 |
Why?
|
Sentinel Surveillance | 3 | 2013 | 281 | 0.110 |
Why?
|
Drug Resistance, Microbial | 2 | 2008 | 860 | 0.110 |
Why?
|
Washington | 2 | 2012 | 313 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 3 | 2012 | 1032 | 0.100 |
Why?
|
Colonic Diseases, Functional | 2 | 2002 | 38 | 0.100 |
Why?
|
Birth Weight | 4 | 2002 | 2068 | 0.100 |
Why?
|
Recurrence | 5 | 2010 | 8333 | 0.100 |
Why?
|
Matrix Metalloproteinase 8 | 2 | 2001 | 56 | 0.100 |
Why?
|
Nutrition Surveys | 4 | 2012 | 1656 | 0.100 |
Why?
|
Minnesota | 1 | 2012 | 343 | 0.100 |
Why?
|
Obstetric Labor, Premature | 3 | 2001 | 279 | 0.100 |
Why?
|
Seroepidemiologic Studies | 3 | 2008 | 402 | 0.100 |
Why?
|
Chlamydia | 1 | 2011 | 33 | 0.100 |
Why?
|
HIV Infections | 6 | 2012 | 16678 | 0.100 |
Why?
|
Anus Neoplasms | 1 | 1995 | 332 | 0.100 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2001 | 140 | 0.090 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3611 | 0.090 |
Why?
|
Alcohol Drinking | 6 | 2000 | 3957 | 0.090 |
Why?
|
Homosexuality, Male | 3 | 2012 | 1238 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2012 | 15056 | 0.090 |
Why?
|
Urban Population | 3 | 2006 | 2018 | 0.090 |
Why?
|
Amniotic Fluid | 2 | 2001 | 366 | 0.090 |
Why?
|
Risk-Taking | 2 | 2009 | 986 | 0.090 |
Why?
|
Safe Sex | 1 | 2009 | 141 | 0.080 |
Why?
|
Philadelphia | 1 | 2009 | 263 | 0.080 |
Why?
|
Lung | 3 | 2009 | 9826 | 0.080 |
Why?
|
International Classification of Diseases | 2 | 2011 | 865 | 0.080 |
Why?
|
Reproductive Health Services | 1 | 2009 | 80 | 0.080 |
Why?
|
Urachal Cyst | 1 | 1988 | 7 | 0.080 |
Why?
|
Infant, Low Birth Weight | 3 | 1987 | 850 | 0.080 |
Why?
|
Medical Audit | 2 | 2011 | 467 | 0.080 |
Why?
|
Urachus | 1 | 1988 | 18 | 0.080 |
Why?
|
Stillbirth | 1 | 2011 | 346 | 0.080 |
Why?
|
Immunoenzyme Techniques | 2 | 2002 | 1799 | 0.080 |
Why?
|
Hospitals, Municipal | 1 | 1987 | 19 | 0.080 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2014 | 806 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2012 | 1402 | 0.080 |
Why?
|
Female Urogenital Diseases | 2 | 2011 | 52 | 0.080 |
Why?
|
Trichomonas Vaginitis | 1 | 2007 | 35 | 0.080 |
Why?
|
Case Management | 1 | 2009 | 286 | 0.080 |
Why?
|
Pregnancy in Adolescence | 1 | 2009 | 157 | 0.080 |
Why?
|
Monocytes | 3 | 2002 | 2593 | 0.080 |
Why?
|
Prisons | 1 | 2009 | 160 | 0.070 |
Why?
|
Exhalation | 1 | 2008 | 166 | 0.070 |
Why?
|
Financing, Government | 1 | 2011 | 468 | 0.070 |
Why?
|
Puerperal Infection | 1 | 1987 | 46 | 0.070 |
Why?
|
Trichomonas vaginalis | 1 | 2007 | 76 | 0.070 |
Why?
|
Office Visits | 2 | 2009 | 598 | 0.070 |
Why?
|
Mycoplasma Infections | 1 | 1987 | 118 | 0.070 |
Why?
|
Twins, Dizygotic | 1 | 1987 | 236 | 0.070 |
Why?
|
Tennessee | 1 | 2006 | 117 | 0.070 |
Why?
|
Indiana | 1 | 2006 | 92 | 0.070 |
Why?
|
Object Attachment | 1 | 2009 | 313 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 14720 | 0.070 |
Why?
|
Abdominal Neoplasms | 1 | 2008 | 290 | 0.070 |
Why?
|
Southeastern United States | 1 | 2006 | 95 | 0.070 |
Why?
|
Electromagnetic Phenomena | 1 | 2007 | 161 | 0.070 |
Why?
|
Risk Factors | 23 | 2012 | 72145 | 0.070 |
Why?
|
Hospitals, Special | 1 | 2006 | 101 | 0.070 |
Why?
|
Specialization | 2 | 2009 | 777 | 0.070 |
Why?
|
Electronic Mail | 1 | 2008 | 213 | 0.070 |
Why?
|
Carboplatin | 2 | 2006 | 799 | 0.070 |
Why?
|
Hospitals, Public | 1 | 1987 | 207 | 0.070 |
Why?
|
Radiotherapy, Conformal | 1 | 2009 | 548 | 0.070 |
Why?
|
Twins | 1 | 1987 | 339 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1184 | 0.070 |
Why?
|
Medical Records | 3 | 2008 | 1413 | 0.070 |
Why?
|
Private Practice | 1 | 2006 | 154 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 1995 | 1195 | 0.070 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 2005 | 29 | 0.070 |
Why?
|
Brain Diseases | 1 | 1994 | 1554 | 0.070 |
Why?
|
Infertility, Male | 1 | 2008 | 407 | 0.060 |
Why?
|
Bisexuality | 1 | 2007 | 270 | 0.060 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2005 | 61 | 0.060 |
Why?
|
Middle Aged | 27 | 2012 | 213127 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 617 | 0.060 |
Why?
|
Socioeconomic Factors | 4 | 2008 | 7770 | 0.060 |
Why?
|
Gold | 1 | 2008 | 483 | 0.060 |
Why?
|
Health Services | 1 | 2009 | 758 | 0.060 |
Why?
|
Sepsis | 1 | 1998 | 2589 | 0.060 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2008 | 482 | 0.060 |
Why?
|
Puerto Rico | 1 | 2005 | 356 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2295 | 0.060 |
Why?
|
Northwestern United States | 3 | 2013 | 20 | 0.060 |
Why?
|
Chlamydiaceae Infections | 1 | 2003 | 2 | 0.060 |
Why?
|
Attitude | 1 | 2008 | 772 | 0.060 |
Why?
|
Guideline Adherence | 2 | 2006 | 2266 | 0.060 |
Why?
|
California | 2 | 2005 | 1400 | 0.060 |
Why?
|
Fever | 2 | 2001 | 1612 | 0.060 |
Why?
|
Sex Offenses | 2 | 2009 | 352 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15530 | 0.060 |
Why?
|
Delivery, Obstetric | 4 | 2001 | 904 | 0.060 |
Why?
|
Maternal Age | 2 | 2002 | 802 | 0.060 |
Why?
|
Cervix Uteri | 2 | 2002 | 591 | 0.050 |
Why?
|
Urethral Diseases | 1 | 2002 | 53 | 0.050 |
Why?
|
Male Urogenital Diseases | 1 | 2002 | 48 | 0.050 |
Why?
|
Thailand | 1 | 2003 | 296 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2011 | 2049 | 0.050 |
Why?
|
Infertility, Female | 1 | 2008 | 784 | 0.050 |
Why?
|
Serotonin Antagonists | 1 | 2002 | 146 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5133 | 0.050 |
Why?
|
Extraembryonic Membranes | 1 | 2001 | 41 | 0.050 |
Why?
|
Bronchoscopy | 1 | 2007 | 860 | 0.050 |
Why?
|
Pharyngeal Diseases | 1 | 2002 | 132 | 0.050 |
Why?
|
Colorado | 2 | 2000 | 162 | 0.050 |
Why?
|
Rectal Diseases | 1 | 2002 | 142 | 0.050 |
Why?
|
Hospitals, Maternity | 1 | 2001 | 42 | 0.050 |
Why?
|
Thienamycins | 1 | 2000 | 27 | 0.050 |
Why?
|
Antibodies, Bacterial | 2 | 2008 | 1469 | 0.050 |
Why?
|
Texas | 3 | 2009 | 392 | 0.050 |
Why?
|
Urine | 1 | 2002 | 370 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 1 | 2002 | 1374 | 0.050 |
Why?
|
Age Factors | 8 | 2009 | 18355 | 0.050 |
Why?
|
Carbazoles | 1 | 2022 | 226 | 0.050 |
Why?
|
DNA, Bacterial | 2 | 2003 | 1465 | 0.050 |
Why?
|
Ceftazidime | 1 | 2000 | 68 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2001 | 118 | 0.050 |
Why?
|
Epidemiologic Research Design | 1 | 2004 | 367 | 0.050 |
Why?
|
Pneumonia | 2 | 2009 | 2117 | 0.050 |
Why?
|
Carbolines | 1 | 2002 | 265 | 0.050 |
Why?
|
Pregnancy Outcome | 2 | 2002 | 2795 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1385 | 0.050 |
Why?
|
Cross-Sectional Studies | 8 | 2012 | 24913 | 0.050 |
Why?
|
Urethra | 1 | 2002 | 408 | 0.050 |
Why?
|
Attitude of Health Personnel | 2 | 2009 | 3839 | 0.050 |
Why?
|
Treatment Failure | 2 | 2005 | 2615 | 0.050 |
Why?
|
Breast | 1 | 2009 | 1958 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2000 | 69 | 0.050 |
Why?
|
Abortion, Spontaneous | 1 | 1985 | 542 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2004 | 1364 | 0.040 |
Why?
|
Physicians | 2 | 2009 | 4554 | 0.040 |
Why?
|
Growth | 1 | 2002 | 376 | 0.040 |
Why?
|
Postoperative Care | 1 | 2006 | 1484 | 0.040 |
Why?
|
Granulocytes | 1 | 2001 | 546 | 0.040 |
Why?
|
Women's Health | 1 | 2009 | 2034 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2012 | 19862 | 0.040 |
Why?
|
Polymerase Chain Reaction | 4 | 2007 | 6171 | 0.040 |
Why?
|
Information Systems | 1 | 2002 | 410 | 0.040 |
Why?
|
Erythromycin | 2 | 1997 | 120 | 0.040 |
Why?
|
Logistic Models | 7 | 2008 | 13403 | 0.040 |
Why?
|
Premature Birth | 1 | 2011 | 1713 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2011 | 9941 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2007 | 1009 | 0.040 |
Why?
|
Mexican Americans | 2 | 2012 | 166 | 0.040 |
Why?
|
Paclitaxel | 1 | 2006 | 1707 | 0.040 |
Why?
|
DNA Probes | 1 | 2000 | 560 | 0.040 |
Why?
|
Statistics as Topic | 1 | 1985 | 2372 | 0.040 |
Why?
|
Fetal Diseases | 1 | 2004 | 903 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2706 | 0.040 |
Why?
|
Magnesium | 1 | 2002 | 813 | 0.040 |
Why?
|
Anesthetics, General | 1 | 2000 | 152 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2009 | 3164 | 0.040 |
Why?
|
Zinc | 1 | 2002 | 683 | 0.040 |
Why?
|
Infant | 5 | 2008 | 35070 | 0.040 |
Why?
|
Sulfisoxazole | 1 | 1997 | 8 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2012 | 77098 | 0.040 |
Why?
|
Specimen Handling | 1 | 2002 | 692 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2002 | 494 | 0.040 |
Why?
|
Infant, Premature | 1 | 1987 | 2041 | 0.040 |
Why?
|
Personality Inventory | 1 | 2000 | 1026 | 0.040 |
Why?
|
Brain | 4 | 2002 | 26343 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 7010 | 0.040 |
Why?
|
Central Nervous System Depressants | 1 | 1998 | 167 | 0.040 |
Why?
|
Fetal Organ Maturity | 1 | 1996 | 82 | 0.040 |
Why?
|
Amoxicillin | 1 | 1997 | 170 | 0.040 |
Why?
|
Fluconazole | 1 | 1996 | 146 | 0.040 |
Why?
|
Meningitis, Cryptococcal | 1 | 1996 | 63 | 0.030 |
Why?
|
Child | 7 | 2011 | 77478 | 0.030 |
Why?
|
Cryptococcus neoformans | 1 | 1996 | 119 | 0.030 |
Why?
|
Health Policy | 1 | 2008 | 2657 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4554 | 0.030 |
Why?
|
Incidence | 4 | 2008 | 20928 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3014 | 0.030 |
Why?
|
Cohort Studies | 6 | 2011 | 40450 | 0.030 |
Why?
|
Rhodamine 123 | 1 | 1995 | 38 | 0.030 |
Why?
|
Uremia | 2 | 2002 | 200 | 0.030 |
Why?
|
Prospective Studies | 11 | 2011 | 53187 | 0.030 |
Why?
|
Hepatitis B | 1 | 2001 | 695 | 0.030 |
Why?
|
Carcinoma | 1 | 2007 | 2374 | 0.030 |
Why?
|
Povidone | 1 | 1995 | 33 | 0.030 |
Why?
|
Bone Marrow Purging | 1 | 1995 | 109 | 0.030 |
Why?
|
Neutropenia | 1 | 2000 | 891 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 1995 | 313 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2721 | 0.030 |
Why?
|
Registries | 1 | 2011 | 8077 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2006 | 11001 | 0.030 |
Why?
|
Rectum | 2 | 2002 | 903 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1659 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2000 | 546 | 0.030 |
Why?
|
Health Promotion | 1 | 2006 | 2194 | 0.030 |
Why?
|
Silicon Dioxide | 1 | 1995 | 213 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1602 | 0.030 |
Why?
|
Psychology | 2 | 2011 | 355 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2002 | 1175 | 0.030 |
Why?
|
New Jersey | 2 | 2000 | 290 | 0.030 |
Why?
|
Patient Compliance | 2 | 2006 | 2680 | 0.030 |
Why?
|
Linear Models | 2 | 2001 | 5948 | 0.030 |
Why?
|
Atrial Natriuretic Factor | 1 | 1995 | 393 | 0.030 |
Why?
|
Adolescent Health Services | 2 | 2009 | 215 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2002 | 12017 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2002 | 1780 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2001 | 1389 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2000 | 984 | 0.030 |
Why?
|
Social Support | 2 | 1999 | 2117 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2013 | 3915 | 0.030 |
Why?
|
Drug Combinations | 1 | 1997 | 1961 | 0.030 |
Why?
|
Boston | 3 | 2000 | 9305 | 0.030 |
Why?
|
Anal Canal | 1 | 1995 | 376 | 0.030 |
Why?
|
Missouri | 1 | 2011 | 116 | 0.030 |
Why?
|
Receptors, Dopamine D2 | 1 | 1994 | 475 | 0.030 |
Why?
|
Pre-Eclampsia | 1 | 2001 | 1196 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 1994 | 427 | 0.020 |
Why?
|
Shock, Septic | 1 | 1998 | 773 | 0.020 |
Why?
|
Drug Utilization | 1 | 1997 | 1181 | 0.020 |
Why?
|
Ethanol | 1 | 1998 | 1337 | 0.020 |
Why?
|
Multivariate Analysis | 4 | 2007 | 12242 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 13853 | 0.020 |
Why?
|
Abortion, Induced | 2 | 2009 | 458 | 0.020 |
Why?
|
Patient Selection | 2 | 2007 | 4214 | 0.020 |
Why?
|
Osmolar Concentration | 2 | 2001 | 683 | 0.020 |
Why?
|
Heterosexuality | 1 | 2012 | 271 | 0.020 |
Why?
|
Health Services Research | 2 | 2014 | 1834 | 0.020 |
Why?
|
Cyclosporins | 1 | 1990 | 220 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2002 | 2536 | 0.020 |
Why?
|
Drug Costs | 1 | 1997 | 1104 | 0.020 |
Why?
|
Sex Education | 1 | 2009 | 93 | 0.020 |
Why?
|
Interviews as Topic | 2 | 2007 | 2536 | 0.020 |
Why?
|
Women's Health Services | 1 | 2009 | 93 | 0.020 |
Why?
|
Sodium | 1 | 1995 | 1627 | 0.020 |
Why?
|
Regression Analysis | 2 | 1996 | 6452 | 0.020 |
Why?
|
Sexuality | 1 | 2010 | 174 | 0.020 |
Why?
|
New York | 1 | 2011 | 886 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2012 | 1794 | 0.020 |
Why?
|
Penicillins | 1 | 1991 | 378 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2014 | 670 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2006 | 8621 | 0.020 |
Why?
|
Tomography, Emission-Computed | 2 | 2002 | 1144 | 0.020 |
Why?
|
Calcium | 1 | 2002 | 5753 | 0.020 |
Why?
|
Time Factors | 7 | 2009 | 40054 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2011 | 39004 | 0.020 |
Why?
|
Health Care Costs | 2 | 2014 | 3203 | 0.020 |
Why?
|
Nociceptors | 2 | 2002 | 432 | 0.020 |
Why?
|
Medicaid | 2 | 2000 | 2716 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3391 | 0.020 |
Why?
|
Ureaplasma | 1 | 1987 | 59 | 0.020 |
Why?
|
Georgia | 1 | 1987 | 185 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 392 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1995 | 1677 | 0.020 |
Why?
|
Health Expenditures | 1 | 2000 | 2346 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 1995 | 2513 | 0.020 |
Why?
|
Endometritis | 1 | 1987 | 48 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1503 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 1988 | 166 | 0.020 |
Why?
|
Alaska | 2 | 1997 | 68 | 0.020 |
Why?
|
Mycoplasma | 1 | 1987 | 139 | 0.020 |
Why?
|
Acute Disease | 1 | 1997 | 7141 | 0.020 |
Why?
|
Neoplasms | 2 | 2014 | 21596 | 0.020 |
Why?
|
Diverticulum | 1 | 1988 | 136 | 0.020 |
Why?
|
Urography | 1 | 1988 | 313 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1520 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7901 | 0.020 |
Why?
|
Developed Countries | 1 | 2009 | 436 | 0.020 |
Why?
|
Marriage | 2 | 1985 | 338 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2012 | 1871 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4414 | 0.020 |
Why?
|
Travel | 1 | 2012 | 788 | 0.020 |
Why?
|
Aged | 13 | 2007 | 162944 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5522 | 0.020 |
Why?
|
Selection Bias | 1 | 2007 | 369 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1995 | 1442 | 0.020 |
Why?
|
Self Concept | 1 | 2011 | 1025 | 0.020 |
Why?
|
Animals | 6 | 2010 | 168561 | 0.020 |
Why?
|
District of Columbia | 1 | 2005 | 157 | 0.020 |
Why?
|
Quinolones | 1 | 2008 | 366 | 0.020 |
Why?
|
Risk Assessment | 3 | 2002 | 23320 | 0.020 |
Why?
|
Risk | 2 | 1987 | 9679 | 0.020 |
Why?
|
Thoracotomy | 1 | 2006 | 363 | 0.020 |
Why?
|
Marital Status | 2 | 1997 | 437 | 0.020 |
Why?
|
Immunoassay | 1 | 2008 | 752 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1994 | 6483 | 0.020 |
Why?
|
Government Regulation | 1 | 2008 | 522 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 1999 | 4250 | 0.010 |
Why?
|
Child Health Services | 1 | 2009 | 667 | 0.010 |
Why?
|
Intrauterine Devices | 1 | 1985 | 122 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4564 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2005 | 8829 | 0.010 |
Why?
|
Ligase Chain Reaction | 1 | 2003 | 8 | 0.010 |
Why?
|
Psychiatry | 1 | 1996 | 1695 | 0.010 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 489 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1987 | 1368 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13655 | 0.010 |
Why?
|
Primary Prevention | 1 | 2010 | 1166 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2009 | 20774 | 0.010 |
Why?
|
Analysis of Variance | 3 | 1999 | 6365 | 0.010 |
Why?
|
Alleles | 1 | 1994 | 6931 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1650 | 0.010 |
Why?
|
Aged, 80 and over | 6 | 2007 | 57683 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2002 | 43 | 0.010 |
Why?
|
Sex Factors | 3 | 2000 | 10392 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11472 | 0.010 |
Why?
|
Vagina | 1 | 2007 | 825 | 0.010 |
Why?
|
Program Development | 1 | 2008 | 1314 | 0.010 |
Why?
|
Behavior Therapy | 1 | 2007 | 866 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2002 | 203 | 0.010 |
Why?
|
Amniocentesis | 1 | 2001 | 116 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2732 | 0.010 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 210 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1661 | 0.010 |
Why?
|
Proportional Hazards Models | 3 | 2001 | 12344 | 0.010 |
Why?
|
Quality of Life | 2 | 1999 | 12730 | 0.010 |
Why?
|
Treatment Outcome | 6 | 2008 | 62966 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9274 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2009 | 1927 | 0.010 |
Why?
|
Ion Transport | 1 | 2002 | 320 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2003 | 891 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2002 | 525 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9185 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2000 | 191 | 0.010 |
Why?
|
Attitude to Health | 1 | 2009 | 2051 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2004 | 676 | 0.010 |
Why?
|
ROC Curve | 2 | 1998 | 3528 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2009 | 4369 | 0.010 |
Why?
|
Taxoids | 1 | 2003 | 665 | 0.010 |
Why?
|
Depression | 1 | 1999 | 7733 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4030 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1990 | 5519 | 0.010 |
Why?
|
Child, Preschool | 2 | 2000 | 40955 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2000 | 232 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2002 | 981 | 0.010 |
Why?
|
Rats | 3 | 2002 | 24265 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1999 | 228 | 0.010 |
Why?
|
Case-Control Studies | 3 | 2002 | 21719 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1988 | 2585 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1987 | 2133 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1309 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 3913 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2000 | 341 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10943 | 0.010 |
Why?
|
Remission Induction | 1 | 2003 | 2384 | 0.010 |
Why?
|
Urban Health | 1 | 2000 | 547 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5062 | 0.010 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 1996 | 19 | 0.010 |
Why?
|
Anxiety | 1 | 2011 | 4279 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1052 | 0.010 |
Why?
|
Ohio | 1 | 1997 | 337 | 0.010 |
Why?
|
Software | 1 | 2011 | 4434 | 0.010 |
Why?
|
Oregon | 1 | 1996 | 140 | 0.010 |
Why?
|
Hospitalization | 1 | 1996 | 10232 | 0.010 |
Why?
|
United States Public Health Service | 1 | 1996 | 31 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1990 | 2986 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2000 | 1902 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1767 | 0.010 |
Why?
|
Marijuana Abuse | 1 | 2000 | 402 | 0.010 |
Why?
|
Schizophrenia | 1 | 1995 | 6874 | 0.010 |
Why?
|
Cell Count | 1 | 2000 | 1831 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5385 | 0.010 |
Why?
|
Aging | 1 | 1995 | 8626 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 1998 | 389 | 0.010 |
Why?
|
Survival Analysis | 2 | 1999 | 10248 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 1987 | 3766 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2000 | 694 | 0.010 |
Why?
|
Rehabilitation, Vocational | 1 | 1995 | 82 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 4929 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1995 | 449 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2885 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1995 | 918 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4982 | 0.010 |
Why?
|
Hospital Charges | 1 | 1996 | 362 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 1879 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 170 | 0.010 |
Why?
|
Candida albicans | 1 | 1996 | 394 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1999 | 1769 | 0.010 |
Why?
|
Spinal Cord | 1 | 2002 | 1807 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2005 | 3465 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1999 | 2557 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 2271 | 0.010 |
Why?
|
Biomedical Research | 1 | 2008 | 3306 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1995 | 625 | 0.010 |
Why?
|
CHO Cells | 1 | 1995 | 1407 | 0.010 |
Why?
|
Length of Stay | 2 | 1996 | 6294 | 0.010 |
Why?
|
Pneumonectomy | 1 | 1999 | 1093 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 1999 | 13921 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2471 | 0.010 |
Why?
|
Fathers | 1 | 1994 | 357 | 0.010 |
Why?
|
Antigens, CD | 1 | 2001 | 4024 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5975 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3335 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8300 | 0.010 |
Why?
|
Infection Control | 1 | 1998 | 962 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1997 | 1232 | 0.010 |
Why?
|
Social Environment | 1 | 1995 | 1023 | 0.010 |
Why?
|
Career Choice | 1 | 1996 | 743 | 0.010 |
Why?
|
Interprofessional Relations | 1 | 1996 | 1008 | 0.010 |
Why?
|
Palliative Care | 1 | 2004 | 3478 | 0.010 |
Why?
|
HeLa Cells | 1 | 1995 | 3127 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 1999 | 2575 | 0.010 |
Why?
|
Comorbidity | 1 | 2003 | 10372 | 0.010 |
Why?
|
Uterine Cervicitis | 1 | 1988 | 30 | 0.000 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1995 | 798 | 0.000 |
Why?
|
Arousal | 1 | 1994 | 1165 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1995 | 2699 | 0.000 |
Why?
|
Insurance, Health | 1 | 2000 | 2493 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3510 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 35342 | 0.000 |
Why?
|
Reaction Time | 1 | 1994 | 2092 | 0.000 |
Why?
|
Medicine | 1 | 1996 | 941 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6313 | 0.000 |
Why?
|
Protamines | 1 | 1987 | 106 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2002 | 19223 | 0.000 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1988 | 224 | 0.000 |
Why?
|
Forecasting | 1 | 1996 | 2948 | 0.000 |
Why?
|
Apoptosis | 1 | 2002 | 9715 | 0.000 |
Why?
|
Liver | 1 | 2002 | 7470 | 0.000 |
Why?
|
Activities of Daily Living | 1 | 1995 | 2414 | 0.000 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1987 | 482 | 0.000 |
Why?
|
Cell Survival | 1 | 1995 | 5872 | 0.000 |
Why?
|
Bone Marrow | 1 | 1995 | 2941 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1988 | 20086 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6030 | 0.000 |
Why?
|
Polysaccharides, Bacterial | 1 | 1987 | 578 | 0.000 |
Why?
|
Phenotype | 1 | 2001 | 16331 | 0.000 |
Why?
|
Complement System Proteins | 1 | 1987 | 795 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2505 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2542 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1996 | 3527 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1994 | 4801 | 0.000 |
Why?
|
Base Sequence | 1 | 1994 | 12797 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1995 | 2229 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 11039 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1987 | 1274 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1994 | 6974 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 18112 | 0.000 |
Why?
|
Parity | 1 | 1984 | 929 | 0.000 |
Why?
|
Chronic Disease | 1 | 1995 | 9144 | 0.000 |
Why?
|
Antibodies | 1 | 1987 | 2459 | 0.000 |
Why?
|
Electroencephalography | 1 | 1994 | 6142 | 0.000 |
Why?
|
Family | 1 | 1988 | 3144 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1995 | 21821 | 0.000 |
Why?
|
Cognition | 1 | 1994 | 6722 | 0.000 |
Why?
|
Cell Line | 1 | 1987 | 15994 | 0.000 |
Why?
|
Mice | 1 | 1995 | 81045 | 0.000 |
Why?
|